Editorial
Copyright ©2013 Baishideng. All rights reserved.
World J Rheumatol. Jul 12, 2013; 3(2): 6-8
Published online Jul 12, 2013. doi: 10.5499/wjr.v3.i2.6
Adrenocorticotropic hormone: A powerful but underappreciated therapeutic tool for acute crystal induced arthritis?
Dimitrios Daoussis, Andrew P Andonopoulos
Dimitrios Daoussis, Andrew P Andonopoulos, Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, 26504 Patras, Greece
Author contributions: Daoussis D and Andonopoulos AP analyzed the data and drafted the manuscript.
Correspondence to: Dimitrios Daoussis, MD, Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Rion, 26504 Patras, Greece. jimdaoussis@hotmail.com
Telephone: +30-2613-603693 Fax: +30-2610-993982
Received: March 21, 2013
Revised: April 23, 2013
Accepted: June 1, 2013
Published online: July 12, 2013
Core Tip

Core tip: The treatment of acute gout in patients with multiple comorbodities is problematic. Adrenocorticotropic hormone (ACTH) is an effective, safe and easy to use therapeutic tool for these patients. ACTH is probably the most attractive choice. Evidence suggests that it is safe and does not seem to associate with immunussupperssion; moreover ACTH is a low cost drug at least in Europe.